Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Zhiqin Zhang(Zhongnan Hospital of Wuhan University), Xiaoyan Wu(Sichuan University)
Diabetes Metabolic Syndrome and Obesity
January 1, 2021
Cited by 35


Related Papers